Navigation Links
VersaPulse 60 Watt

ProductsVersaPulse 60 Watt
Company Lumenis, Inc.
Item VersaPulse 60 Watt
Features 
  • Highest power holmium laserup to 100 watts with 2 joules at 50 hertzprovides the smoothest cutting, faster, more efficient tissue effect, and reduced OR time
  • Upgrade capability for current and future applications
  • The only combination holmium/Nd:YAG laser system that provides multiple tissue effects through one delivery device
  • Compact size simplifies transportation and set-up
  • Solid state design with thirty-second warm-up for immediate use and problem-free maintenance
  • Over twenty fiber delivery systems compatible with multiple endoscopes
    • Description The VersaPulse PowerSuite holmium laser combines excellent cutting, ablation and coagulation properties for precise, virtually bloodless procedures. It is also extremely effective in fragmenting urinary and gall bladder stones of all compositions, making it an ideal multipurpose surgical tool. Because its laser light is transmitted through flexible fibers, it is especially suited for minimally invasive endoscopic and laparoscopic procedures. The VersaPulse PowerSuite system comes in a variety of low- to high-power holmium models plus a combination holmium and neodymium:YAG (Nd:YAG) configuration. Lumenis is the pioneer in laser and light-based technology. Since introducing the first medical laser in 1970, over 60,000 systems have been used by nearly every medical specialty. Since introducing the first holmium laser in 1991, Lumenis has helped to expand the medical applications of this relatively new multipurpose laser. Today, holmium technology has been proven in thousands of procedures, securing the holmium laser its place as a well-respected minimally invasive treatment modality and the VersaPulse PowerSuite as the system of choice. VersaPulse PowerSuite lasers are used for ablation, excision, incision, vaporization and immediate hemostasis of soft tissues through endoscopic, laparoscopic and open access for a wide variety of surgical applications and procedures.
    Info Lumenis, Inc.
    Customer Service: 877-lumenis
    Web site: http://www.lumenis.com

    Related medicine products :

    1. VersaPulse® 20 Watt
    2. VersaPulse® 60 Watt
    3. VersaPulse® 100 Watt
    4. VersaPulse® 80/100 Watt
    5. VersaPulse 20 Watt
    6. VersaPulse 80/100 Watt
    7. VersaPulse 100 Watt
    8. Lumenis VersaPulse PowerSuite
    ...ovascular ultrasound system is the world's first s...d real-time 4D and multi-dimensional imaging capab... the Vivid 7 family, provides clinicians with new ...s such as heart failure in patients., ,Vivid 7...
    ...tem is intended for use in lumbar spinal fusion pr...System - is introduced into the prepared intervert...meter. It is then EXPANDED up to 15mm (depending o... within the intervertebral space., ,The B-Twin...
    ...ardiovascular system that brings a new level of im...on of comfort and diagnostic confidence to clinici...igma practices, GE has created the first ergonomic...what customers want: Better image quality for 2D, ...
    Radi invented the guidewire-mounted pressure sensor and continues to lead the way. PressureWire5 Sensor is the only sensor on the market that measures pressure, temperature and flow. With significant
    Medicine Products:
    (Date:11/21/2008)... COLUMBIA, S.C., Nov. 21 /PRNewswire-USNewswire/ -...mmittee for Quality Assurance (NCQA) ranked BlueCh...ird of America,s Best Health Plans(TM), published ... , , The respected annual ranking ranks the...ity, member satisfaction and NCQA accreditation sc...
    (Date:11/21/2008)... FRANKLIN LAKES, N.J., Nov. 21 /PRNewswire-FirstCa...ice for medical intervention in treating 88 percen...0 percent of Americans treated for a chronic condi...ug spending and 75 percent of all medical costs. ...ree years by Medco Health Solutions, Inc. (NYSE: ...
    (Date:11/21/2008)... Study found 2 popular drugs do not cause genetic ...AY, Nov. 21 (HealthDay News) -- Two popular medica... disorder (ADHD) do not cause genetic damage linke...w study says. , The study, done by researchers ... Institutes of Health, counters a previous one tha...
    (Date:11/21/2008)..., In 430 B.C., a new and deadly diseaseits cause ...ek city-state was teeming with citizens, soldiers ... and Sparta. As streets filled with corpses, socia... illness returned twice and Athens lost a third of...f Athens marked the beginning of the end of the Go...
    Breaking Medicine News(10 mins):Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
    ... Apnoea Association (BSSAA) reveals that snoring a...has a detrimental effect on health and ruins sex l...w has brought out an anti snore bedroom which has ...attresses. These are washable and aid people who s...
    ... and muscle cells degrades as we grow older, and t...tion of our muscles to move// , according to Unive...n assistant professor in UD's College of Health Sc...hanges in muscle and neurons, elderly people are o...
    ...ions of different biomolecules (DNA, proteins, etc...e sample for many purposes// technology makes poss...diagnostics. The work, based on tiny customizabl...isease monitoring, drug discovery or genetic profi...
    ...hat more copper in everyday diet could be good for... at the University of Louisville Medical Center// ...ir studies show that giving copper supplements to ...orked hearts by preventing heart enlargement. The ...
    Other Medicine News:Health News:Mobility can be improved in elders with exercise 2Health News:Mobility can be improved in elders with exercise 3Health News:Mobility can be improved in elders with exercise 4Health News:A New Inexpensive Technology for Multiplexed Detection 2Health News:A New Inexpensive Technology for Multiplexed Detection 3
    (Date:11/19/2008)...ewswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) and...iary of,Takeda Pharmaceutical Company Limited (TS...Phase 3 MONET1 trial evaluating motesanib (AMG 706...for the first-line treatment of,advanced non-smal...spended,following a planned safety data review of...
    (Date:11/19/2008)...oche- , , MONTVALE, N.J., Nov. 19 /PRNewswi...daq: MEMY ) today announced that it has achieved...7/MEM 3454, its lead alpha-7 nicotinic receptor ag...izophrenia (CIAS). The Company has randomized 212...million payment from its partner Roche. Memory Ph...
    (Date:11/18/2008)...ces of Influenza survey underscores that mothers n...other and Gold Medalist Kristi Yamaguchi joins ini...e/ -- While 78 percent of mothers in the United St...ife-threatening disease that can strike anyone, on...accinated this season, according to a new survey f...
    (Date:11/12/2008)...SNewswire/ -- A new study being,published in this ...he,question, what causes Parkinson,s disease?, On...search into,Parkinson,s disease is what causes the...place. Answering this question has been especially...types of brain cells that produce,dopamine and the...
    Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Novadaq to hold first quarter 2008 results conference call and webcast 18133 1Novadaq to hold first quarter 2008 results conference call and webcast 18133 2Novadaq to hold first quarter 2008 results conference call and webcast 18133 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 1Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 2Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 4Haunted by hallucinations 3A Children in the PICU traumatized by delusions 18131 1Haunted by hallucinations 3A Children in the PICU traumatized by delusions 18131 2Study raises questions about prostate cancer therapies targeting IGF 1 18128 1Study raises questions about prostate cancer therapies targeting IGF 1 18128 2
    ...CAGO--(BUSINESS WIRE)--Jun 4, 2007 - Genentech, In... a joint analysis of two Phase,III clinical trials...ant treatment of HER2-positive breast cancer. Data...can Society of Clinical,Oncology (ASCO) showed tha...e addition of Herceptin to standard adjuvant thera...
    ...UTH SAN FRANCISCO, Calif., June 04, 2007,/PRNewswi...d,follow-up data from a Phase 2 clinical trial of ... conducted by the Johns Hopkins,Sidney Kimmel Canc...rable pancreatic cancer who received GVAX after su...tion and,chemotherapy. , ,The median overall survi...
    Other Medicine Technology:Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 2Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 3Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 5Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 6Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 2Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 3Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 4Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 5